Stock Analysis
China Feihe (HKG:6186) Full Year 2023 Results
Key Financial Results
- Revenue: CN¥19.5b (down 8.3% from FY 2022).
- Net income: CN¥3.39b (down 31% from FY 2022).
- Profit margin: 17% (down from 23% in FY 2022). The decrease in margin was driven by lower revenue.
- EPS: CN¥0.37 (down from CN¥0.55 in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
China Feihe Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) also missed analyst estimates by 23%.
The primary driver behind last 12 months revenue was the Dairy Products and Nutritional Supplements Products segment contributing a total revenue of CN¥19.3b (99% of total revenue). The largest operating expense was Sales & Marketing costs, amounting to CN¥6.71b (72% of total expenses). Explore how 6186's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Food industry in Hong Kong.
Performance of the Hong Kong Food industry.
The company's shares are up 5.4% from a week ago.
Risk Analysis
It is worth noting though that we have found 1 warning sign for China Feihe that you need to take into consideration.
Valuation is complex, but we're helping make it simple.
Find out whether China Feihe is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:6186
China Feihe
An investment holding company, produces and sells infant milk formula products in Mainland China, Canada, and the United States.
Flawless balance sheet and undervalued.
